FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

BIOCON

389.45
-4.2 (-1.07%)
Updated 03:28 05/06 IST

BIOCON Buy or Sell - FrontPage Forums

1 Users have submitted 1 trade ideas of Rs. 331.1 for BIOCON
Disclaimer
100% Bullish
0% Bearish

BIOCON Ratings

Long term BIOCON rating by FrontPage users
4.2/5 (10 Ratings)
Find answers to all your questions on live BIOCON message board: Is BIOCON buy or sell? Should I buy BIOCON shares? Why are BIOCON shares falling? Should I invest in BIOCON stock?

BIOCON Share Price Discussion

Y
Reputation: 313 • Today 8:55 AM

Type
Buy
Instrument
BIOCON
Entry Price
₹389.5
Price@Trade
₹389.5
Target Price
₹500
Stop Price
₹340
Valid Till
Jun 4, 2021 3:20 AM
Margin
₹389,500 approx for 1000 Qty
Status
Exited
Exit Price
₹389.35
Net P&L
-₹150 (-0.04%)
Like
Reply (1)
Latest replies
Yash @yash-H15s1Tko8
Today 8:57 AM

Update
Exited
Exit Price
₹389.35
Net P&L
-₹150 (-0.04%)
A
Reputation: 2,487 • Today 4:44 AM

Type
Buy
Instrument
BIOCON JUN20 FUT
Entry Price
₹395.35
Price@Trade
₹395.35
Target Price
₹406
Stop Price
₹385
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹344,740.67 approx for 2300 Qty
Status
Exited
Exit Price
₹393.9
Net P&L
-₹3,335 (-0.97%)
Like
Reply (1)
Latest replies
Anish @anish-SyOlsUcHL
Today 7:40 AM

Update
Exited
Exit Price
₹393.9
Net P&L
-₹3,335 (-0.97%)
A
Reputation: 2,487 • Today 3:19 AM

Type
Sell
Instrument
BIOCON JUN20 FUT
Entry Price
₹392
Price@Trade
₹392.3
Target Price
₹383
Stop Price
₹400
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹344,004.1 approx for 2300 Qty
Status
Exited
Exit Price
₹395.3
Net P&L
-₹7,590 (-2.21%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Today 3:20 AM

Update
Trade Entered
Entry Price
₹392
Anish @anish-SyOlsUcHL
Today 4:43 AM

Update
Exited
Exit Price
₹395.3
Net P&L
-₹7,590 (-2.21%)
Reputation: 3,179 • Today 3:16 AM
Kiran Mazumdar-Shaw named EY World Entrepreneur Of The Year 2020, Biocon boss says she won it for her colleagues
She became the third Indian and second woman to win the Award.
The Economic Times
Like
Reply
Reputation: 3,179 • Today 1:18 AM
Kiran Mazumdar Shaw named EY World Entrepreneur Of The Year 2020
Shaw, 67, founded Bangalore-based Biocon Limited in 1978 with just two employees and currently leads the company that is now worth close to Rs 50,000 crore by market-cap and employs more than 11,000 people.
Moneycontrol
Like
Reply
Reputation: 3,179 • Yesterday 7:28 AM
Axis Securities picks 10 stocks that could deliver 10-50% returns in a year
The earnings season to date with a significant number of companies yet to declare results has been tepid with more negative surprises
Moneycontrol
Like
Reply

Type
Buy
Instrument
BIOCON JUN20 FUT
Entry Price
₹389.9
Price@Trade
₹389.9
Target Price
₹465
Stop Price
₹345  ₹390
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹338,320.8 approx for 2300 Qty
Status
Stoploss Hit
Exit Price
₹390
Net P&L
+₹230 (+0.07%)
1
Reply (2)
Latest replies
TRADE WITH TREND @mayurpatel
Yesterday 7:21 AM

Update
Stoploss Trailed
Price @ Update
₹390.2
Original SL
₹345
New SL
₹390
TrackerBot @trackerbot
Yesterday 7:22 AM

Update
Stoploss Hit
Exit Price
₹390

Type
Buy
Instrument
BIOCON JUN20 FUT
Entry Price
₹388.3
Price@Trade
₹388.3
Target Price
₹407.3
Stop Price
₹383
Valid Till
Jun 5, 2020 3:20 AM
Margin
₹335,663 approx for 2300 Qty
Status
Exited
Exit Price
₹396.5
Net P&L
+₹18,860 (+5.62%)
Like
Reply (1)
Latest replies

Update
Exited
Exit Price
₹396.5
Net P&L
+₹18,860 (+5.62%)

Type
Buy
Instrument
BIOCON JUN20 FUT
Entry Price
₹388.3
Price@Trade
₹388.3
Target Price
₹407
Stop Price
₹382
Valid Till
Jun 5, 2020 3:20 AM
Margin
₹335,663 approx for 2300 Qty
Status
Exited
Exit Price
₹388.3
Net P&L
₹0 (0%)
Like
Reply (1)
Latest replies

Update
Exited
Exit Price
₹388.3
Net P&L
₹0 (0%)

Type
Buy
Instrument
BIOCON JUN20 FUT
Entry Price
₹385.65
Price@Trade
₹385.65
Target Price
₹465
Stop Price
₹340  ₹387.65
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹344,005.83 approx for 2300 Qty
Status
Stoploss Hit
Exit Price
₹387.65
Net P&L
+₹4,600 (+1.34%)
Like
Reply (2)
Latest replies
TRADE WITH TREND @mayurpatel
Yesterday 6:29 AM

Update
Stoploss Trailed
Price @ Update
₹387.8
Original SL
₹340
New SL
₹387.65
TrackerBot @trackerbot
Yesterday 6:30 AM

Update
Stoploss Hit
Exit Price
₹387.65

Type
Sell
Instrument
BIOCON JUN20 FUT
Entry Price
₹390
Price@Trade
₹390
Target Price
₹385
Stop Price
₹392.5
Valid Till
Jun 4, 2020 3:20 AM
Margin
₹335,307 approx for 2300 Qty
Status
Exited
Exit Price
₹385.6
Net P&L
+₹10,120 (+3.02%)
Like
Reply (1)
Latest replies
Ashish Paswan @tradingwithashish
Yesterday 5:20 AM

Update
Exited
Exit Price
₹385.6
Net P&L
+₹10,120 (+3.02%)

Type
Buy
Instrument
BIOCON JUN20 FUT
Entry Price
₹392.7
Price@Trade
₹392.7
Target Price
₹406
Stop Price
₹387
Valid Till
Jun 5, 2020 3:20 AM
Margin
₹336,017.35 approx for 2300 Qty
Status
Stoploss Hit
Exit Price
₹387
Net P&L
-₹13,110 (-3.9%)
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
Yesterday 5:21 AM

Update
Stoploss Hit
Exit Price
₹387

Type
Buy
Instrument
BIOCON JUN20 390 CE
Entry Price
₹22.2
Price@Trade
₹22.2
Target Price
₹45
Stop Price
₹4
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹51,060 approx for 2300 Qty
Status
Exited
Exit Price
₹23.35
Net P&L
+₹2,645 (+5.18%)
Like
Reply (1)
Latest replies

Update
Exited
Exit Price
₹23.35
Net P&L
+₹2,645 (+5.18%)

Type
Buy
Instrument
BIOCON JUN20 FUT
Entry Price
₹393.4
Price@Trade
₹393.4
Target Price
₹415
Stop Price
₹380  ₹394.4
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹336,073.7 approx for 2300 Qty
Status
Stoploss Hit
Exit Price
₹394.4
Net P&L
+₹2,300 (+0.68%)
Like
Reply (2)
Latest replies
TRADE WITH TREND @mayurpatel
Yesterday 4:01 AM

Update
Stoploss Trailed
Price @ Update
₹394.75
Original SL
₹380
New SL
₹394.4
TrackerBot @trackerbot
Yesterday 4:01 AM

Update
Stoploss Hit
Exit Price
₹394.4
Reputation: -440 • Jun 3 4:09 AM
Like
Reply
Reputation: 3,179 • Jun 3 8:03 AM
Midcaps may take time to catch-up; 12 names to bet on amid uncertainty
While the large-cap stocks have been rising, experts believe as sectors, mid-caps and small-caps will take a longer time to pick up as bigger companies could be in a better position to grab higher market share in their respective sectors after the lockdown ends.
Moneycontrol
Like
Reply
Reputation: 158 • Jun 2 12:17 PM
Post by ChartArt in BIOCON community on FrontPage
#ChartArt #EducationalPurposes #BIOCON #Bullish | CMP 385 #Unchartedterritory
FrontPage
Like
Reply

BIOCON - chart - 853644
#BIOCON 10 min Elliott Wave Analysis,
Currently We See Wave Four in The Making, After That We Can See the Fifth Wave Going With the Trend, It Can Finish Near The Wave 3 Highs (in that Case it will be truncated fifth fave which failed to cross wave 3, basically a double top type ...
Read more...
2
Reply (1)
Latest replies

Sir nifty and Banknifty view
Reputation: 3,179 • Jun 2 9:38 AM
COVID-19 curve unlikely to flatten anytime soon: Kiran Mazumdar-Shaw
Shaw added that the focus was needed more on flattening the death curve than the infection curve.
Moneycontrol
Like
Reply
Reputation: 13,291 • Jun 2 5:59 AM

Type
Sell
Instrument
BIOCON
Entry Price
₹385  ₹384.95
Price@Trade
₹385.05
Target Price
₹367
Stop Price
₹400
Valid Till
Jun 3, 2020 3:20 AM
Margin
₹19,247.5 approx for 50 Qty
Status
Exited
Exit Price
₹384.6
Net P&L
+₹17.5 (+0.09%)
Like
Reply (3)
Latest replies
King999 @king999
Jun 2 5:59 AM

Update
Entry Price Modified
Price @ Update
₹384.95
Original Entry Price
₹385
New Entry Price
₹384.95
TrackerBot @trackerbot
Jun 2 6:00 AM

Update
Trade Entered
Entry Price
₹384.95
King999 @king999
Jun 3 6:27 AM

Update
Exited
Exit Price
₹384.6
Net P&L
+₹17.5 (+0.09%)
Reputation: -153 • Jun 2 5:33 AM

BIOCON - chart - 851751
Short Sell @ 391.25, SL @ 394.5
Covered @ 389
Early exit.
Not a good RR.
Note: This trade was based on VSA.
Like
Reply

Type
Sell
Instrument
BIOCON
Entry Price
₹387.15
Price@Trade
₹387
Target Price
₹368.35
Stop Price
₹396.55
Valid Till
Jun 2, 2020 3:20 AM
Margin
₹99,884.7 approx for 258 Qty
Status
Validity Over
Exit Price
₹382.2
Net P&L
+₹1,277.1 (+1.28%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Jun 2 5:26 AM

Update
Trade Entered
Entry Price
₹387.15
TrackerBot @trackerbot
Jun 2 8:50 AM

Update
Validity Over
Exit Price
₹382.2
Net P&L
+₹1,277.1 (+1.28%)

Type
Sell
Instrument
BIOCON
Entry Price
₹387.5
Price@Trade
₹387.5
Target Price
₹371.65
Stop Price
₹395.05
Valid Till
Jun 2, 2020 3:20 AM
Margin
₹99,975 approx for 258 Qty
Status
Validity Over
Exit Price
₹382.2
Net P&L
+₹1,367.4 (+1.37%)
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
Jun 2 8:50 AM

Update
Validity Over
Exit Price
₹382.2
Net P&L
+₹1,367.4 (+1.37%)
A
Reputation: -24,276 • Jun 2 2:57 AM

Type
Buy
Instrument
BIOCON JUN20 400 CE
Entry Price
₹17
Price@Trade
₹17
Target Price
₹35
Stop Price
₹14.9
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹39,100 approx for 2300 Qty
Status
Stoploss Hit
Exit Price
₹14.9
Net P&L
-₹4,830 (-12.35%)
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
Jun 2 3:00 AM

Update
Stoploss Hit
Exit Price
₹14.9

Type
Buy
Instrument
BIOCON JUN20 FUT
Entry Price
₹392.5
Price@Trade
₹393
Target Price
₹405
Stop Price
₹386
Valid Till
Jun 2, 2020 3:20 AM
Margin
₹340,026.25 approx for 2300 Qty
Status
Stoploss Hit
Exit Price
₹386
Net P&L
-₹14,950 (-4.4%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Jun 2 2:54 AM

Update
Trade Entered
Entry Price
₹392.5
TrackerBot @trackerbot
Jun 2 3:06 AM

Update
Stoploss Hit
Exit Price
₹386
Reputation: 158 • Jun 2 2:37 AM

BIOCON - chart - 850077
#ChartArt #EducationalPurposes #BIOCON
#Bullish | CMP 385 #Unchartedterritory
1
Reply
Reputation: 3,179 • Jun 1 2:03 AM
Itolizumab, Biocon's drug with Cuban link, in hunt for COVID-19 breakthrough
It has been found that 'cytoskine storm' is the leading cause of deaths of COVID-19. Cytokines stimulate immune system to kill virus. But in COVID-19, the virus tricks our body to produce uncontrollable flood of cytokines, which while helping in fighting virus, also worsens a patient's condition.
Moneycontrol
Like
Reply

Type
Buy
Instrument
BIOCON JUN20 FUT
Entry Price
₹385  ₹385.9
Price@Trade
₹386.05
Target Price
₹405
Stop Price
₹377
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹326,119.88 approx for 2300 Qty
Status
Exited
Exit Price
₹390.5
Net P&L
+₹10,580 (+3.24%)
Like
Reply (3)
Latest replies

Update
Entry Price Modified
Price @ Update
₹385.7
Original Entry Price
₹385
New Entry Price
385.9
TrackerBot @trackerbot
Jun 1 8:59 AM

Update
Trade Entered
Entry Price
385.9

Update
Exited
Exit Price
₹390.5
Net P&L
+₹10,580 (+3.24%)

Type
Buy
Instrument
BIOCON
Entry Price
₹388  ₹387
Price@Trade
₹387.35
Target Price
₹420
Stop Price
₹368
Valid Till
Jul 1, 2020 3:20 AM
Margin
₹77,400 approx for 200 Qty
Status
Exited
Exit Price
₹391
Net P&L
+₹800 (+1.03%)
Like
Reply (3)
Latest replies

Update
Entry Price Modified
Price @ Update
₹387
Original Entry Price
₹388
New Entry Price
₹387
TrackerBot @trackerbot
Jun 1 8:54 AM

Update
Trade Entered
Entry Price
₹387

Update
Exited
Exit Price
₹391
Net P&L
+₹800 (+1.03%)
Reputation: 145,659 • Jun 1 8:40 AM

Type
Buy
Instrument
BIOCON
Entry Price
₹384  ₹384.75
Price@Trade
₹384.5
Target Price
₹430
Stop Price
₹365
Valid Till
Jul 1, 2020 3:20 AM
Margin
₹3,078,000 approx for 8000 Qty
Status
Exited
Exit Price
₹394.55
Net P&L
+₹78,400 (+2.55%)
1
Reply (3)
Latest replies
Vinstock @vinstock
Jun 1 8:41 AM

Update
Entry Price Modified
Price @ Update
₹384.75
Original Entry Price
₹384
New Entry Price
₹384.75
TrackerBot @trackerbot
Jun 1 8:42 AM

Update
Trade Entered
Entry Price
₹384.75
Vinstock @vinstock
Jun 2 2:49 AM

Update
Exited
Exit Price
₹394.55
Net P&L
+₹78,400 (+2.55%)

Type
Buy
Instrument
BIOCON JUN20 FUT
Entry Price
₹384
Price@Trade
₹384.75
Target Price
₹430
Stop Price
₹370
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹326,083.65 approx for 2300 Qty
Status
Exited
Exit Price
₹386.15
Net P&L
+₹4,945 (+1.52%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Jun 1 8:35 AM

Update
Trade Entered
Entry Price
₹384

Update
Exited
Exit Price
₹386.15
Net P&L
+₹4,945 (+1.52%)
Reputation: 2,913 • Jun 1 5:12 AM
Pyramidstock in BIOCON
buy biocon cmp 353-352 btst trade sl 340 tgt 36...

from 352 to 369.40 almost final tgt 370 done book and trade close will update fresh trade #BIOCON
Like
Reply
Z
Reputation: -34 • Jun 1 5:11 AM

Type
Buy
Instrument
BIOCON
Entry Price
₹368.5
Price@Trade
₹367.7
Target Price
₹370
Stop Price
₹367
Valid Till
Jun 1, 2020 3:20 AM
Margin
₹184,250 approx for 500 Qty
Status
Target Achieved
Exit Price
₹370
Net P&L
+₹750 (+0.41%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Jun 1 5:16 AM

Update
Trade Entered
Entry Price
₹368.5
TrackerBot @trackerbot
Jun 1 5:20 AM

Update
Target Achieved
Exit Price
₹370
Z
Reputation: -34 • Jun 1 4:53 AM

Type
Buy
Instrument
BIOCON
Entry Price
₹364.2
Price@Trade
₹363.95
Target Price
₹367.2
Stop Price
₹361.2
Valid Till
Jun 1, 2020 3:20 AM
Margin
₹364,200 approx for 1000 Qty
Status
Target Achieved
Exit Price
₹367.2
Net P&L
+₹3,000 (+0.82%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Jun 1 4:58 AM

Update
Trade Entered
Entry Price
₹364.2
TrackerBot @trackerbot
Jun 1 5:07 AM

Update
Target Achieved
Exit Price
₹367.2
R
Reputation: 1,653 • Jun 1 4:06 AM

Type
Buy
Instrument
BIOCON
Entry Price
₹361.7
Price@Trade
₹361.65
Target Price
₹375
Stop Price
₹357  ₹368.5
Valid Till
Jul 1, 2020 3:20 AM
Margin
₹361,700 approx for 1000 Qty
Status
Stoploss Hit
Exit Price
368.5
Net P&L
+₹6,800 (+1.88%)
Like
Reply (4)
Latest replies
TrackerBot @trackerbot
Jun 1 4:07 AM

Update
Trade Entered
Entry Price
₹361.7
ROHAN @rohan9401
Jun 1 5:18 AM

Update
Stoploss Trailed
Price @ Update
₹369.5
Original SL
₹357
New SL
367.5
ROHAN @rohan9401
Jun 1 5:21 AM

Update
Stoploss Trailed
Price @ Update
₹370.15
Original SL
₹367.5
New SL
368.5
TrackerBot @trackerbot
Jun 1 5:34 AM

Update
Stoploss Hit
Exit Price
368.5
Reputation: 2,913 • Jun 1 3:58 AM
Pyramidstock in BIOCON
buy biocon cmp 353-352 btst trade sl 340 tgt 36...

from 352 to 362 1st tgt done safe player book and rest keep sl at cost n hold #BIOCON
Like
Reply
Reputation: 3,179 • Jun 1 3:28 AM
Biocon share price up 2% on favourable ruling from US PTAB
The PTAB also found Sanofi’s proposed amended claims for the ‘486 and ‘844 patents unpatentable.
Moneycontrol
Like
Reply
S
Reputation: 1,364 • Jun 1 3:20 AM

Type
Buy
Instrument
BIOCON JUN20 FUT
Entry Price
₹357.8
Price@Trade
₹357.8
Target Price
₹363
Stop Price
₹356
Valid Till
Jun 1, 2020 3:20 AM
Margin
₹310,483.9 approx for 2300 Qty
Status
Exited
Exit Price
₹361.15
Net P&L
+₹7,705 (+2.48%)
Like
Reply (1)
Latest replies
Senthil @senthil180
Jun 1 3:55 AM

Update
Exited
Exit Price
₹361.15
Net P&L
+₹7,705 (+2.48%)
Reputation: 3,179 • May 30 11:48 AM
Vaccine to prevent COVID-19 will take long time to be ready: Kiran Mazumdar-Shaw
She was speaking in a webinar on 'Pharma and Healthcare's New Normal: Engaging With Customers in Uncertain Times; Business Model Post-COVID-19', organised by CorpGini.
Moneycontrol
Like
Reply
Reputation: 2,913 • May 29 8:42 AM

buy biocon cmp 353-352 btst trade sl 340 tgt 360-370 #BIOCON
Like
Reply
Reputation: 9,406 • May 29 8:35 AM

Type
Buy
Instrument
BIOCON JUN20 FUT
Entry Price
₹351.25
Price@Trade
₹351.25
Target Price
₹385
Stop Price
₹335
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹316,403.53 approx for 4600 Qty
Status
Exited
Exit Price
₹352
Net P&L
+₹3,450 (+1.09%)
Like
Reply (1)
Latest replies
Sam Sir @samsirs
May 29 8:58 AM

Update
Exited
Exit Price
₹352
Net P&L
+₹3,450 (+1.09%)
R
Reputation: 281 • May 29 5:10 AM
Q. Any chance for moving up?
Like
Reply (4)
Latest replies
Ajay @AjayN
May 29 8:09 AM

Yes. But what's ur buy price?
Raphael  @raphael
May 29 8:10 AM

Bought 360 CE...at 13
Ajay @AjayN
May 29 8:10 AM

Oh. I am not good at options
King999 @king999
May 30 10:24 AM

If hold 345 levels on closing basis then am expecting target of 370/390 in coming days..
Reputation: 3,179 • May 28 9:48 AM
Lockdown has to end: Kiran Mazumdar-Shaw
"I think now there is anyway no point in extending the lockdown because of exodus of the migrant labour; they have basically gone to various parts of the country without any controls. So, now there is no point trying to extend lockdown any further. Now, its a question of quickly bringing under control any outbreak," Mazumdar-Shaw said.
Moneycontrol
Like
Reply
S
Reputation: -360 • May 28 4:28 AM

Type
Sell
Instrument
BIOCON
Entry Price
₹347.2
Price@Trade
₹347.2
Target Price
₹346
Stop Price
₹348
Valid Till
May 28, 2020 3:20 AM
Margin
₹347,200 approx for 1000 Qty
Status
Stoploss Hit
Exit Price
₹348
Net P&L
-₹800 (-0.23%)
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
May 28 5:21 AM

Update
Stoploss Hit
Exit Price
₹348
Reputation: 9,406 • May 28 2:50 AM

Type
Buy
Instrument
BIOCON JUN20 FUT
Entry Price
₹343.5
Price@Trade
₹343.5
Target Price
₹369.8
Stop Price
₹335.8
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹308,232.98 approx for 4600 Qty
Status
Exited
Exit Price
₹344.3
Net P&L
+₹3,680 (+1.19%)
Like
Reply (1)
Latest replies
Sam Sir @samsirs
May 28 3:10 AM

Update
Exited
Exit Price
₹344.3
Net P&L
+₹3,680 (+1.19%)
Reputation: 9,406 • May 27 8:43 AM

Type
Buy
Instrument
BIOCON MAY20 FUT
Entry Price
₹349.9
Price@Trade
₹349.9
Target Price
₹369.8
Stop Price
₹348
Valid Till
May 28, 2020 3:20 AM
Margin
₹619,751.42 approx for 4600 Qty
Status
Stoploss Hit
Exit Price
₹348
Net P&L
-₹8,740 (-1.41%)
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
May 27 8:52 AM

Update
Stoploss Hit
Exit Price
₹348
Reputation: 9,406 • May 27 6:15 AM

Type
Buy
Instrument
BIOCON MAY20 FUT
Entry Price
₹352.5
Price@Trade
₹352.75
Target Price
₹369
Stop Price
₹348
Valid Till
May 28, 2020 3:20 AM
Margin
₹623,216.4 approx for 4600 Qty
Status
Exited
Exit Price
₹352.65
Net P&L
+₹690 (+0.11%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
May 27 6:16 AM

Update
Trade Entered
Entry Price
₹352.5
Sam Sir @samsirs
May 27 7:13 AM

Update
Exited
Exit Price
₹352.65
Net P&L
+₹690 (+0.11%)
Reputation: 9,406 • May 27 6:02 AM

Type
Buy
Instrument
BIOCON MAY20 FUT
Entry Price
₹353.85
Price@Trade
₹353.85
Target Price
₹369.8
Stop Price
₹352.8
Valid Till
May 28, 2020 3:20 AM
Margin
₹624,553.75 approx for 4600 Qty
Status
Exited
Exit Price
₹353.8
Net P&L
-₹230 (-0.04%)
Like
Reply (1)
Latest replies
Sam Sir @samsirs
May 27 6:06 AM

Update
Exited
Exit Price
₹353.8
Net P&L
-₹230 (-0.04%)
S
Reputation: -5,129 • May 27 6:00 AM

Type
Buy
Instrument
BIOCON
Entry Price
₹354.5  ₹354.8
Price@Trade
₹355
Target Price
₹364.2
Stop Price
₹350
Valid Till
May 28, 2020 3:20 AM
Margin
₹816,040 approx for 2300 Qty
Status
Stoploss Hit
Exit Price
₹350
Net P&L
-₹11,040 (-1.35%)
Like
Reply (3)
Latest replies
Shantanu Jha @shanu
May 27 6:02 AM

Update
Entry Price Modified
Price @ Update
₹354.8
Original Entry Price
₹354.5
New Entry Price
₹354.8
TrackerBot @trackerbot
May 27 6:03 AM

Update
Trade Entered
Entry Price
₹354.8
TrackerBot @trackerbot
May 27 8:51 AM

Update
Stoploss Hit
Exit Price
₹350
Reputation: 9,406 • May 27 5:51 AM

Type
Buy
Instrument
BIOCON MAY20 FUT
Entry Price
₹353.35
Price@Trade
₹353.35
Target Price
₹369
Stop Price
₹348
Valid Till
May 28, 2020 3:20 AM
Margin
₹623,945.86 approx for 4600 Qty
Status
Exited
Exit Price
₹353.95
Net P&L
+₹2,760 (+0.44%)
Like
Reply (1)
Latest replies
Sam Sir @samsirs
May 27 5:57 AM

Update
Exited
Exit Price
₹353.95
Net P&L
+₹2,760 (+0.44%)
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • BIOCON - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization36,660
    Enterprise Value36,305
    Price to Earnings149.8
    Price to Book Value5.15
    Return on Capital Employed0.04
    Return on Equity0.04
    Face Value5
    Dividend YieldNA
  • BIOCON - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    18-May-20Nirmal BangSell272
    18-May-20Axis DirectBuy474
    27-Jan-20ICICIdirect.comHold310
    27-Jan-20Nirmal BangSell252
    27-Jan-20Motilal OswalNeutral300
    BIOCON Brokerage Price Target
  • BIOCON Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jun 5397400.5388.6389.6
    Jun 4382.5395.75382393.65
    Jun 3387390381.35382.5
    Jun 2389396381.2382.7
    Jun 1360389.9357.45385.5
  • BIOCON Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹355.94
    30 Day Moving Average₹355.18
    50 Day Moving Average₹336.83
    100 Day Moving Average₹315.03
    200 Day Moving Average₹284.01
  • BIOCON - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue2,4252,587.9-0.06
    Operating Profit318591.8-0.46
    Profit Before Tax305536.2-0.43
    Net Income238519.3-0.54
  • BIOCON - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds7,1156,7370.06
    Total Liabilities1,1251,0450.08
    Total Assets8,2407,7830.06
  • BIOCON - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity355185.80.91
    Cash from Investing Activity-553104-6.32
    Cash from Financing Activity-54-238.3-0.77
    Net Cash Flow-25251.5-5.89
  • BIOCON - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.030.07
    Return on Equity0.040.08
    Return on Capital Employed0.040.08
  • BIOCON - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.08
    3 Year CAGR Growth in Operating Profit-0.22
    3 Year CAGR Growth in EBIDTA-0.21
    3 Year CAGR Growth in Net Income-0.34
    3 Yr CAGR Growth - Diluted EPS-0.78
  • BIOCON - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.25
    5 Year CAGR Growth in Operating Profit-0.18
    5 Year CAGR Growth in EBIDTANA
    5 Year CAGR Growth in Net Income-0.14
    3 Yr CAGR Growth - Diluted EPS-0.71
  • BIOCON - Recent News

    keyboard_arrow_down
    NewsBot
    Today 3:16 AM
    Kiran Mazumdar-Shaw named EY World Entrepreneur Of The Year 2020, Biocon boss says she won it for her colleagues
    The Economic Times
    NewsBot
    Today 1:18 AM
    Kiran Mazumdar Shaw named EY World Entrepreneur Of The Year 2020
    Moneycontrol
    NewsBot
    Jun 2 9:38 AM
    COVID-19 curve unlikely to flatten anytime soon: Kiran Mazumdar-Shaw
    Moneycontrol
    NewsBot
    Jun 1 2:03 AM
    Itolizumab, Biocon's drug with Cuban link, in hunt for COVID-19 breakthrough
    Moneycontrol
    NewsBot
    Jun 1 3:28 AM
    Biocon share price up 2% on favourable ruling from US PTAB
    Moneycontrol
    NewsBot
    May 30 11:48 AM
    Vaccine to prevent COVID-19 will take long time to be ready: Kiran Mazumdar-Shaw
    Moneycontrol
    NewsBot
    May 28 9:48 AM
    Lockdown has to end: Kiran Mazumdar-Shaw
    Moneycontrol
    NewsBot
    May 27 5:03 AM
    Biocon gains on DCGI approval for use of CytoSorb to treat critical COVID-19 patients
    Moneycontrol
    NewsBot
    May 27 4:28 AM
    Biocon gets drug regulator's nod for CytoSorb device to treat critical COVID-19 patients
    Moneycontrol
    NewsBot
    May 21 3:03 AM
    Biocon Consolidated March 2020 Net Sales at Rs 1,581.00 crore, up 3.41% Y-o-Y
    Moneycontrol
  • BIOCON - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
  • BIOCON - More Information

    keyboard_arrow_down

    Biocon Ltd:
    Biocon Limited is a biopharmaceutical firm in India, engaged in developing, manufacturing and selling pharmaceutical products for oncology, diabetes and autoimmune diseases in the nation as well as abroad. The company has several sectors of operations such as small molecules, branded formulations, research services and more.
    The company is manufacturing insulin lispro, insulin glargine, insulin aspart, recombinant human insulin, monoclonal antibodies, small molecules viz. generic formulations and active pharmaceutical ingredients and more, along with botanical products. Besides that, the company has branded formulation products under brands such as Insugen, BIOMAb, ALZUMAb, EGFR, Basalog and CANMAb. Biocon Limited has certifications such as ISO 9001, ISO 14001:2004, ISO 9001:2000, ISO 15189:2003 and OHSAS 18001:1999. The company has been developing its entire research system based upon small and large molecules, oligonucleotides and antibody-drug conjugates. Clinigene International Ltd and Syngene International Ltd are the two subsidiaries of Biocon Limited. The company has a global intervention in approximately 120 countries.
    About Company Information:
    Biocon Limited was incepted in 1978 and is headquartered in Bangalore, India. Biocon Limited was found when an Indian entrepreneur signed a joint venture with Ireland based firm Biocon Biochemicals Limited in 1978. The company started manufacturing and exporting enzymes to USA and Europe from 1979. Biocon Biochemicals Limited was acquired by Unilever plc and merged with Unilever’s subsidiary Quest International.
    In 1990, the company enhanced its in-house research programme by introducing new technologies. In 1993, the R&D, along with manufacturing facilities of the company, was certified ISO 9001 by RWTUV, Germany. Syngene International Pvt. Ltd was incorporated by the company in 1994 as a Custom Research Company for addressing the exponentially increasing need for outsourced Research & Development in the pharmaceutical sector.
    Developing an efficient manufacturing facility, Biocon Limited started to venture its initiatives for human healthcare in the medicine market and business since 1997. In 1998, Unilever had gone for a deal with ICI for selling its speciality chemicals division, which includes Quest International.
    A totally automated submerged fermentation plant, for the first time in its history of operation, was commissioned by the company in 2000, for manufacturing speciality pharmaceuticals. Clinigene, India’s first Clinical Research Organisation for providing clinical research and development was commissioned by the company in 2000. US FSA approved Biocon Limited as India’s first pharmaceutical company to manufacture the cholesterol-lowering molecule lovastatin.
    In 2005, a commercial agreement was signed by Biocon Limited for supplying insulin API to Asia, Africa and the Middle East. Nation’s largest biotechnology hub, having an integrated set up of manufacturing facilities and research laboratories with a spreading of 90 acres in Karnataka Industrial Areas Development Board—namely, Biocon Park was established by the company in 2006. Country’s largest multi-product Biologics facility was also established at Biocon Park.
    An MoU was signed between Biocon and Neopharma, resulting as a joint venture firm Neobiocon in July 2007. A strategic partnership was established between the company and IATRICa, Inc for developing jointly a range of immunoconjugates regarding the immunotherapy of cancers and infectious diseases in January 2008.
    BASALOG, long-lasting basal insulin for Type 1 & Type 2 Diabetics were introduced by Biocon Limited in 2009. Biocon Cell was launched as the resultant of the partnership between Biocon Limited and ISB for Innovation Management in the same year. AxiCorp GmbH, the German subsidiary of Biocon had been sold by the company in 2011, to its existing promoters and shareholders. ALZUMAb, was launched by Biocon Limited in 2013 for the psoriasis patients in India.
    In 2014, CANMAb – Trastuzumab, a medicine for the treatment of breast cancer was launched by the company in India. A world-class premium devices facility was inaugurated by Biocon at Bangalore in 2015 along with the introduction of Basalog One in India. Mylan and Biocon jointly submitted a proposal for Biosimilar Trastuzumab to USFDA in 2016.
    Biocon Limited declared that along with Mylan it is going to enhance the introduction of adalimumab biosimilar in Europe, as Mylan has an in-licensing arrangement with Fujifilm Kyowa Kirin Biologics.
    How Biocon Ltd, is categorised as a Pharmaceutical and Healthcare Sector, and Pharmaceutical Industry :
    The Pharmaceutical Industry includes companies that derive their business by researching, discovering, developing, manufacturing, and marketing and distributing pharmaceutical medicines and drugs.
    Biocon Ltd is categorized under the Health care sector and Hospitals and Medical services Industry. Healthcare sectors consist of firms involved in the medical space. It is one of the multiple sectors that comprise a range of businesses, including ones that offer medical services directly, or to those that work to develop, create and market medical equipment and medicines. It also includes the other services that provide medical insurance and other related products, and many more.
    The stocks of health care companies mostly have mixed performance. It is due to the inherent challenges to the industry each year, regulatory uncertainties, fiscal policy concerns, and more.
    Biocon Ltd, Competitors and Sector Peers:
    Aarey Drugs & Pharmaceuticals Ltd. AARDRU
    Aarti Drugs Ltd. AARTDR
    Aayush Food & Herbs Ltd. AAYFOO
    Abbott India Ltd. ABBIND
    ABL Bio-Technologies Ltd. ABLBIO
    Addlife Pharma Ltd. ADDPHA
    Advik Laboratories Ltd. ADVLAB
    Ahlcon Parenterals (India) Ltd. AHLPAR
    Ajanta Pharma Ltd. AJAPHL
    Aurobindo Pharma Ltd. AUROBP
    Bharat Immunological & Biologicals Corporation Ltd. BHAIMM
    Biofil Chemicals & Pharmaceuticals Ltd. BIOCHE
    Biowin Pharma (India) Ltd. BIOPHA
    Bliss GVS Pharma Ltd. BLIGVS
    Brabourne Enterprises Ltd.[Amalgamated] RPGLIF
    Brawn Biotech Ltd. BRAPHA
    Brooks Laboratories Ltd. BROLAB
    Cadila Healthcare Ltd. CADHEA
    Caplin Point Laboratories Ltd. CAPPOI
    Cipla Ltd. CIPLTD
    Claris Lifesciences Ltd. CORELA
    Colinz Laboratories Ltd. COLILA
    Combat Drugs Ltd. COMDRU
    Concord Drugs Ltd. CONDRU
    Coral Laboratories Ltd. CORLAB
    Desh Rakshak Aushdhalaya Ltd. DESRAK
    DIL Ltd. DILLIM
    Divi's Laboratories Ltd. DIVIL
    Dolphin Laboratories Ltd. DOLLAB
    Dr. Datsons Labs Ltd. AANLIF
    Dr. Reddy's Laboratories Ltd. DR
    Dujohn Laboratories Ltd. DUJLAB
    Ganga Pharmaceuticals Ltd. GANPHA
    Gennex Laboratories Ltd. GENLAB
    Genomics Biotech Ltd. GENBIO
    GlaxoSmithKline Pharmaceuticals Ltd. GLAPHA
    Glenmark Pharmaceuticals Ltd. GLEPHL
    IOL Chemicals and Pharmaceuticals Ltd. IOLCHE
    Ipca Laboratories Ltd. IPCLAB
    Ishita Drugs & Industries Ltd. ISHDRU
    J B Chemicals & Pharmaceuticals Ltd. JBCH
    Jagsonpal Pharmaceuticals Ltd. JAGPHA
    Jenburkt Pharmaceuticals Ltd. JENPHA
    JK Pharmachem Ltd. JKPHAL
    Jubilant Life Sciences Ltd. JUBILO
    Jupiter Bioscience Ltd. JUPIBI
    Kabra Drugs Ltd. KABDRU
    Kamron Laboratories Ltd. KAMLAB
    Lincoln Pharmaceuticals Ltd. LINPHA
    Lupin Ltd. LUPLTD
    Lyka Labs Ltd. LYKLAB
    Madhuveer Com 18 Network Ltd. TOHPHA
    Mahavir Advanced Remedies Ltd. INDAME
    Makers Laboratories Ltd. MAKLAB
    Mangalam Drugs and Organics Ltd. MANDRU
    New Heaven Chemicals and Industries Ltd. TRAMED
    NGL Fine - Chem Ltd. NGLFIN
    Norris Medicines Ltd. NORMED
    Novartis India Ltd. NOVAIN
    Nutraplus India Ltd. NUTPRO
    Omega Labora.Ltd. OMELAB
    Oriental Remedies & Herbals Ltd. ORIREM
    Ortin Laboratories Ltd. ORTLAB
    Piramal Enterprises Ltd. NICPIR
    Procter & Gamble Health Ltd. MERCLT
    Ranbaxy Laboratories Ltd. RANLAB
    RPG Life Sciences Ltd. RPGLI
    Rubra Medicaments Ltd. RUBMED
    Sanofi India Ltd. AVEPHA
    Sun Pharmaceutical Industries Ltd. SUN28
    Trans Asia Corporation Ltd. TRAASI
    Wockhardt Ltd. WOCLTD
    Wyeth Ltd. WYELTD
    Yogi Healthcare Ltd. COREHE
    Zenith Healthcare Ltd. ZENHEA
    Zenlabs Ethica Ltd. SHRLAK
    Zenotech Laboratories Ltd. ZENLAB
    Zyden Gentec Ltd. ZYDGEN
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020